Meta's Threads to test direct messaging feature in select markets
June 10 (Reuters) - Meta Platforms (META.O), opens new tab said it would start rolling out direct messaging on its Threads app, adding a feature long offered by rivals, in a bid to attract more users.
Users in select markets, including Hong Kong and Thailand, will get a dedicated inbox for direct messages on the app as part of the test, eliminating the need to switch to Instagram's messaging platform, CEO Mark Zuckerberg said on Tuesday.
Meta said messages on Threads will not be encrypted for now.
Threads and Instagram have long been intertwined as part of Meta's plans to leverage the image and video sharing platform's massive user base to better compete with services such as X, TikTok and Reddit (RDDT.N), opens new tab for digital ad dollars.
Launched in 2023 as a competitor to Elon Musk's X, then known as Twitter, following his chaotic takeover of the platform, Threads quickly attracted consumers and now boasts over 350 million monthly active users.
Meta announced the expansion of advertising on Threads to all eligible advertisers globally in April. However, the company has said it did not expect Threads to be a "meaningful driver" of revenue growth in 2025.
Research firm Emarketer expects Threads' U.S. monthly active users will grow 17.5% to 60.5 million by next year, surpassing X, whose user base is expected to decline 14.4% to 50 million.
U.S. trade restrictions and the rise of AI‑powered ad targeting have pushed social media platforms to enhance their offerings, adding distinctive features and sharper user experiences to stand out in a saturated market.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
2 hours ago
- Times
Alan Grieve
In the late 1950s Alan Grieve was a bright young lawyer making his name in company and tax law at the legal firm Taylor & Humbert. Among its clients was John Jerwood, an enigmatic British millionaire living in Tokyo who had made his fortune in the postwar years through one of the world's largest cultured-pearl dealerships. Senior partners regarded Jerwood as 'a little difficult' and were delighted to palm him off to Grieve. He began travelling the world with his client, who was soon also his friend and confidant. The pair bonded over the arts and in 1977 Jerwood, advised by Grieve, started the Jerwood Foundation as a personal vehicle for supporting music and educational projects. 'He had no children but he had money and liked education and the arts,' Grieve told The Independent, adding on another occasion: 'He wanted to give people that next step up.'
Reuters
5 hours ago
- Reuters
India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma
June 29 (Reuters) - India's Torrent Pharmaceuticals ( opens new tab said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals ( opens new tab from New York-based investment firm KKR (KKR.N), opens new tab, and plans to merge the two drugmakers. The transaction, announced in a joint statement released by the three companies, implies a total equity valuation of 256.89 billion rupees ($3.01 billion) for JB Pharma on a fully diluted basis. "This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and building a larger diversified global presence," Torrent Executive Chairman Samir Mehta said in the statement. Under the terms of the deal, Torrent will initially acquire an equity stake in JB Pharma from KKR for 119.17 billion rupees. Following this, Torrent will launch a mandatory open offer to acquire up to an additional 26% of JB Pharma shares from public shareholders at 1,639.18 rupees per share. Torrent also signaled its intent to acquire up to 2.80% of equity shares from certain JB Pharma employees, the company said. The second phase of the transaction involves a merger of Torrent and JB Pharma through a scheme of arrangement. Upon merger, JB Pharma shareholders will receive 51 Torrent shares for every 100 JB Pharma shares held. KKR also confirmed the deal in a separate statement. "We are confident that the combined strengths of our organizations will unlock greater opportunities to enhance healthcare access across our markets," said JB Pharma CEO Nikhil Chopra. India is Torrent's biggest market by revenue, where it competes with peers such as Mankind Pharma ( opens new tab. Torrent offers drugs used to treat cancer, infections and diabetes, and has benefited from steady demand for its specialty and chronic illness drugs. For the January-March quarter, its consolidated net profit was up 11% from a year earlier. JB Chemicals and Pharmaceuticals, meanwhile, reported higher fourth-quarter profit in May. Along with the steady market for its gastrointestinal medicines, Metrogyl and Sporlac, the company also benefitted from demand for its drugs that treat chronic conditions such as hypertension. ($1 = 85.4400 Indian rupees)
Reuters
7 hours ago
- Reuters
China resumes qualified seafood imports from some Japan regions
BEIJING, June 29 (Reuters) - China on Sunday announced it is immediately resuming seafood products imported from some Japanese regions, ending a nearly two-year overall ban imposed due to worries over Japan's release of treated wastewater from the Fukushima nuclear power plant. In a notice on Sunday, China Customs said seafood products from 10 prefectures - Fukushima, Gunma, Tochigi, Ibaraki, Miyagi, Niigata, Nagano, Saitama, Tokyo and Chiba - will still be banned from entering the country. Products from other regions will need health certificates, radioactive substance detection qualification certificates and production area certificates issued by the Japanese government for Chinese customs declarations, the notice said. Chinese customs authorities said Sunday's decision was made after no abnormality was detected following long-term international and independent Chinese sampling and monitoring of discharged wastewater. China banned all imports of Japanese seafood in August 2023, shortly after Tokyo began releasing the treated Fukushima wastewater, prompting a diplomatic and economic backlash. Sunday's notice said China will strictly supervise Japanese seafood imports and will take measures if it finds any violations of relevant Chinese laws, regulations and food safety standards.
